SYNCHRONICITY - Clinical Trial

¿Cuál es el Propósito de este estudio?

The SYNCHRONICITY study is a test to compare two treatments for people with heart failure and a heart electrical problem called left bundle branch block. People in the study will be randomly chosen to get one of two devices: a new type called LBBAP or a regular type called CRT. First, they will have surgery to put in the device. Then, they will have checkups at 6 months, 12 months, and once a year for up to 5 years. At these visits, doctors will check the device, do heart tests, and ask how the person feels. The study wants to find out which device is safer and works better.

¿Cuál es la Condición que se está estudiando?

The study is for people who have a heart problem called heart failure with reduced ejection fraction. This means their heart does not pump blood well. They also have an electrical problem in the heart called left bundle branch block. To join, they must have a very weak heart pump, symptoms like feeling tired or short of breath, and need a special device called CRT-D. Healthy people cannot join this study.

¿Quién puede participar en el Estudio?

To join the SYNCHRONICITY study, people must be at least 18 years old and agree to take part. They need to have heart failure with a very weak heart pump and symptoms like tiredness or trouble breathing, even after taking heart medicine for 3 months. They must also have a heart rhythm problem called left bundle branch block, shown on a heart test called an ECG. They need to qualify for a special heart device called CRT-D and another device to prevent dangerous heart rhythms. Finally, they must agree to come to all study visits and use remote monitoring.

Grupo etario
Adultos

¿Qué Implica?

The SYNCHRONICITY study wants to learn if a new way to help the heart beat, called left bundle branch area pacing (LBBAP), is safe and works well. This new method will be compared to the usual treatment called cardiac resynchronization therapy (CRT). The study is for people who have heart failure and an electrical problem in their heart. The goal is to see if LBBAP can help people live longer and feel better.

Detalles del Estudio

Título Completo
Safety and Effectiveness of Left Bundle Branch Area Pacing versus Conventional Cardiac Resynchronization Therapy in Heart Failure
Investigador Principal
Daniel J. Friedman, MD
Especialista en electrofisiología
Número de Protocolo
IRB: PRO00118920
NCT: NCT07069738
Fase
Phase III
ClinicalTrials.gov
Estado de inscripción
Abierto para inscripción
Apoye la investigación de Duke Health o rinda homenaje a un ser querido con un regalo conmemorativo.
Contribuya a Duke Health